Kemwell Biopharma

Kemwell Biopharma

Products
Kemwell Biopharma
Kemwell Biopharma

Information

SERVICES Kemwell provides integrated development and manufacturing services for companies that require one-stop solution for mammalian cell-culture based protein therapeutics The team is experienced to undertake end-to-end activities right from cell line development till cGMP clinical and commercial manufacturing. Kemwell also undertakes standalone projects such as process optimisation, analytical method development or validation, formulation development and optimization, stability studies, resin reuse study, tech transfer and cGMP manufacturing, process characterization, etc.
Product Categories
  • Innovative APIs
    • Antibodies
    Service Categories
    • Contract Research Organisations (CROs)
      • Bio Analytical Services
      Distribution Areas
      North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South Asia (e.g. India, Pakistan, Sri Lanka)
      Kemwell BiopharmaKemwell Biopharma is a leading biologics CDMO based in Bengaluru, India, offering end-to-end services from cell line and process development to cGMP clinical and commercial manufacturing. Its 15,000 sq. m facility, built with Boehringer Ingelheim, includes 5,000 L bioreactor capacity and sterile fill-finish for vials and PFS. In October 2025, Kemwell completed a U.S. FDA PAI for an injectable drug product, reinforcing its global quality standards and trusted partnerships since 1980.Kemwell specializes in mammalian cell-based biologics, including mAbs, complex proteins and biosimilars.

      Log in

      See all the content and easy-to-use features by logging in or registering!